Body image, sexual health, anxiety worse after bilateral mastectomy
TUESDAY, Oct. 27, 2020 (HealthDay News) — Young breast cancer survivors who undergo more extensive surgery have worse body image, sexual health, and anxiety compared with women undergoing less extensive surgery, according to a study recently published in JAMA Surgery.
Shoshana M. Rosenberg, Sc.D., from the Dana-Farber Cancer Institute in Boston, and colleagues evaluated the associations of different surgery types with quality of life and psychosocial outcomes from one to five years following diagnosis among 826 young women with breast cancer undergoing surgery.
Forty-five percent of patients underwent bilateral mastectomy (BM), 31 percent had breast-conserving surgery (BCS), and 24 percent had unilateral mastectomy (UM). The researchers found that the vast majority of women (84 percent) who had BM/UM had reconstruction. Sexuality and body image were consistently worse (higher adjusted mean scores) among women who had BM versus BCS or UM. Adjusted mean anxiety scores remained higher among women who had BM versus BCS/UM at one, two, and five years. Between-group differences for depression levels were minimal in follow-up.”Ensuring young women are aware of the short-term and long-term effects of surgery and receive support when making surgical decisions is warranted,” the authors write.
One author disclosed financial ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
PET/MRI Offers Diagnostic, Prognostic Value in Pediatric Epilepsy
Dense Breast Notification Linked to Increase in Use of Supplemental Ultrasound
Less Intraoperative Crystalloid Fluid Not Tied to Worse Surgical Outcomes
Mammography Trials Yield Excess-Incidence Patterns Consistent With Low Overdiagnosis
Lower Breast, Cervical Cancer Screening Seen for Adults With Disabilities
Alcohol-Attributable Cancer Mortality Has Increased Significantly in the U.S.
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer
AMH Predicts Benefit of Chemo + Endocrine Therapy in Under 55s With Breast Cancer